| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1834 | 2018 |
| Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon … B Mlecnik, C Bifulco, G Bindea, F Marliot, A Lugli, JJ Lee, I Zlobec, TT Rau, ... Journal of Clinical Oncology 38 (31), 3638, 2020 | 163 | 2020 |
| Turning the tide against regulatory T cells SJ Han, A Toker, ZQ Liu, PS Ohashi Frontiers in oncology 9, 279, 2019 | 64 | 2019 |
| Coenzyme A fuels T cell anti-tumor immunity MS Paul, SD Saibil, SJ Han, K Israni-Winger, SC Lien, RC Laister, ... Cell metabolism 33 (12), 2415-2427. e6, 2021 | 42 | 2021 |
| IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function M St. Paul, SD Saibil, SC Lien, SJ Han, A Sayad, DT Mulder, ... Cancer immunology research 8 (3), 321-333, 2020 | 36 | 2020 |
| A naturally occurring transcript variant of MARCO reveals the SRCR domain is critical for function KE Novakowski, A Huynh, SJ Han, MG Dorrington, C Yin, Z Tu, P Pelka, ... Immunology and cell biology 94 (7), 646-655, 2016 | 36 | 2016 |
| Age-associated remodeling of T cell immunity and metabolism SJ Han, P Georgiev, AE Ringel, AH Sharpe, MC Haigis Cell metabolism 35 (1), 36-55, 2023 | 26 | 2023 |
| Fcmr regulates mononuclear phagocyte control of anti-tumor immunity SP Kubli, L Vornholz, G Duncan, W Zhou, P Ramachandran, J Fortin, ... Nature communications 10 (1), 2678, 2019 | 17 | 2019 |
| Multicenter international study of the consensus immunoscore for the prediction of relapse and survival in early-stage colon cancer B Mlecnik, A Lugli, G Bindea, F Marliot, C Bifulco, JKJ Lee, I Zlobec, ... Cancers 15 (2), 418, 2023 | 14 | 2023 |
| Overproduction of IL-2 by Cbl-b deficient CD4+ T cells provides resistance against regulatory T cells SJ Han, DC Chung, M St. Paul, ZQ Liu, C Garcia-Batres, AR Elford, ... Oncoimmunology 9 (1), 1737368, 2020 | 13 | 2020 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016 S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ... Journal for ImmunoTherapy of Cancer 4, 223-242, 2016 | 9 | 2016 |
| Clinical performance of the consensus immunoscore in colon cancer in the Asian population from the multicenter international SITC study B Mlecnik, T Torigoe, G Bindea, B Popivanova, M Xu, T Fujita, S Hazama, ... Cancers 14 (18), 4346, 2022 | 8 | 2022 |
| Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity SJ Han, ZQ Liu, DC Chung, MS Paul, CR Garcia-Batres, A Sayad, ... Cancer Immunology Research 10 (4), 437-452, 2022 | 8 | 2022 |
| Regulatory T Cells in Dominant Immunological Tolerance P Georgiev, M Benamar, SJ Han, MC Haigis, AH Sharpe, TA Chatila Journal of Allergy and Clinical Immunology, 2023 | 2 | 2023 |
| Metabolic modulation of mitochondrial mass during CD4+ T cell activation K Kurmi, D Liang, R van de Ven, P Georgiev, BM Gassaway, SJ Han, ... Cell Chemical Biology 30 (9), 1064-1075. e8, 2023 | 1 | 2023 |
| The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada MCA Wouters, CM Laumont, B Chen, SJ Han, K Matuszewska, K Potts, ... Cancer Immunology, Immunotherapy 66, 811-818, 2017 | 1 | 2017 |
| The role of Cbl-b in CD4+ T cell resistance to regulatory T cell suppression SJ Han, L Chapatte, PS Ohashi The Journal of Immunology 196 (1_Supplement), 125.20-125.20, 2016 | 1 | 2016 |
| Deciphering the effects of age on T cell immunity and immunotherapy SJ Han, P Georgiev, J Schneider, A Huang, Z Nugmanova, TH Nguyen, ... Cancer Research 84 (6_Supplement), 6592-6592, 2024 | | 2024 |
| Metabolic vulnerabilities of dedifferentiated liposarcoma JO Brett, JS Han, C Kim, LP Kelley, SJ Han, D Boone, J Crowley, S Joshi, ... Cancer Research 84 (6_Supplement), 4425-4425, 2024 | | 2024 |
| Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy MS Paul, SD Saibil, M Kates, SJ Han, SC Lien, RC Laister, K Hezaveh, ... Cell Reports Medicine 5 (3), 2024 | | 2024 |
Carlos Garcia-BatresUniversity Health NetworkVerified email at uhnresearch.ca
